Venous thrombosis in SLE Sir, The article by Gladman and Urowitz1 confirmed a susceptibility to venous thrombosis of patients with systemic lupus erythematosus (SLE). Similar observations have been made by Peck, Hoffman, and Franck.2 Neither of these studies was able to define any specific characteristics which pre-disposed patients to venous thrombosis, although it is noteworthy that 3 of the 17 cases described by the former authors had a circulating anticoagulant. They did not state whether this feature was sought in every instance. We have recently described 4 patients in whom recurrent or extensive venous thrombosis was associated with the presence of the lupus coagulation inhibitor. 3 This paradox has been previously noted,4 and in our view is more than a chance association. In our cases further thrombosis was prevented by continuous warfarin treatment over an average period of 6 months. Interestingly, anticoagulation reduced the partial thromboplastin times and made it more difficult to demonstrate the inhibitor. There were no haemorrhagic complications during treatment. We believe that severe venous thrombosis in SLE should suggest the possibility of the lupus circulating anticoagulant, which, if demonstrable, is an indication for long-term anticoagulation.
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